Opinion: Listen: Is the medical system ready for Alzheimer’s drugs that work?
Leqembi is a game-changer for Alzheimer's. But the health care system needs to change to keep up.
An effective treatment for Alzheimer’s disease has long been a holy grail in the pharmaceutical industry. In early June, some hope appeared when the FDA agreed that the anti-amyloid antibody lecanemab (to be sold by Eisai as Leqembi) outperformed placebo in trials. It is expected to receive full approval by July 6.
But this may not necessarily be purely good news.
What's Your Reaction?
